NEW YORK (GenomeWeb News) – GeneNews today announced it has completed its rights offering, raising C$2.6 million ($2.5 million) in gross proceeds.

The Toronto-based molecular diagnostics firm issued a total of more than 23 million common shares under the offering at C$.11 per share. The offering, which was announced in April, was fully prescribed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.